IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Current Trends and Emerging Priorities in Compounded Preparations for Children

Author(s):  Parrish Richard H II

Issue:  Sep/Oct 2018 - Volume 22, Number 5
View All Articles in Issue

Abstract:  The problems related to pediatric pharmacotherapeutics and medication management are not unique to any particular country, as drug therapy problems are common causes of emergency department visits. Over the past 20 years, there were only sporadic scientific and commercial efforts to develop unique oral nonsterile dosage forms with a potential for mass production and standardization that would address the needs of pediatric patients under the age of four years with chronic diseases. This article raises awareness of the issues encountered in pharmacy pediatrics practice surrounding compounded nonsterile preparations. Current trends and emerging priorities at the interface between the use of these preparations and patient safety will be discussed. Trends in compounded nonsterile preparations preparation for children include standardization of nomenclature, formulation, dose, re-purposing old medications, reformulating older drugs, increasing federal oversight of pharmacy compounding, and changes to broaden the scope of indications in the product’s label. Among the emerging priorities for safe pediatric compounded nonsterile preparations use include creation of new formulations for expanding pediatric diagnoses, improved quality-control processes described in United States Pharmacopeia Chapter <795>, closing the patient safety gap with changes to the prescription fulfillment systems, and employment of board-certified pediatric pharmacy specialists within the fulfillment process. In particular, an emerging opportunity to close the good clinical practice-good manufacturing practice gap at the pharmacy or point-of-care level with application of reverse-engineering concepts and other novel solutions have the potential to improve a pharmacist’s ability to produce quality pediatric compounded nonsterile preparations. A systems approach (Formulation, Information, Collaboration, and Innovation) to the design of an integrated prescription generation and medication management system for children, including a simulation functionality, would include validation of small batch compounded nonsterile preparations, provision of complete information necessary to verify a prescription order, establishment of models of collaboration between board-certified pediatric clinical pharmacists and pediatricians, and performance of pragmatic clinical trials regarding compounded nonsterile preparation use in children.

Related Keywords: Richard H. Parrish II, BPharm, PhD, FCCP, BCPS, children, infants, drug dosing, drug metabolism, hepatic enzymes, compounded nonsterile preparations, compound safety, formulation errors, medication errors, commercially available, regulatory requirements, standardization

Related Categories: LEGAL, PEDIATRICS, TECHNOLOGY, QUALITY CONTROL, ADVERSE DRUG EVENTS, HOSPITAL PHARMACY

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Current Trends and Emerging Priorities in Compounded Preparations for Children Parrish Richard H II Sep/Oct 2018 358-366 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106-113 Buy
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations Ashe Krystina, Baskett Dustin Sep/Oct 2018 387-398 Buy
Treating Canine Hepatic Disease Davidson Gigi S May/Jun 2003 188-191 Buy
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D May/Jun 2004 181-185 Buy
Basics of Compounding: Standardization of Compounded Medications Allen Loyd V Jr Jan/Feb 2019 35-44 Buy
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms McElhiney Linda F Sep/Oct 2013 364-368 Buy
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc Jan/Feb 2014 6-12 Buy
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Palma Elisabetta, Bufarini Celestino Sep/Oct 2014 358-364 Buy
Setting Up a National System of Compounding Pharmacies: Preventing Error, Assuring Quality, Building Trust Guedes de Souza Hugo, Favaro Alvaro Jr, Andrade Alba Livia, Gomes Lenir Yago, de Souza Aguiar Simone, do Carmo Garcez Maria Nov/Dec 2009 532-536 Buy